PDCD1 and neoplasm: In this study, we found that LTX-315 significantly decreased the Tregs infiltration, significantly down-regulated the PD-1 expression, and significantly up-regulated CTLA-4 expression in residual tumors, which enhanced the tumor response to anti-CTLA-4 antibody treatment.